BR112012008146A2 - composição para alívio dos danos causados por meio da irradiação ultravioleta - Google Patents

composição para alívio dos danos causados por meio da irradiação ultravioleta

Info

Publication number
BR112012008146A2
BR112012008146A2 BR112012008146A BR112012008146A BR112012008146A2 BR 112012008146 A2 BR112012008146 A2 BR 112012008146A2 BR 112012008146 A BR112012008146 A BR 112012008146A BR 112012008146 A BR112012008146 A BR 112012008146A BR 112012008146 A2 BR112012008146 A2 BR 112012008146A2
Authority
BR
Brazil
Prior art keywords
composition
ultraviolet radiation
damage caused
damage
methionine
Prior art date
Application number
BR112012008146A
Other languages
English (en)
Inventor
Mizumoto Chieko
Mita Masashi
Tojo Yosuke
Ashida Yutaka
Original Assignee
Shiseido Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shiseido Co Ltd filed Critical Shiseido Co Ltd
Publication of BR112012008146A2 publication Critical patent/BR112012008146A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0208—Tissues; Wipes; Patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/004—Aftersun preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dispersion Chemistry (AREA)
  • Birds (AREA)
  • Immunology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Mycology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Pulmonology (AREA)
  • Toxicology (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

composição para alívio dos danos causados por meio da irradiação ultravioleta. a presente invenção refere-se a uma composição para aliviar os danos causados por meio da radiação ultravioleta, que é estável e segura e pode ser utilizada em uma base dia-a-dia, e uma composição medicinal, um preparação para a pele externa, uma composição de alimentos e um medicamento para catarata, cada um compreendendo a referida composição para aliviar os danos induzidos por meio da radiação ultravioleta. especificamente descrita é uma composição para aliviar os danos induzidos por meio da radiação ultravioleta, que contém um ou mais tipos de compostos selecionados a partir do grupo consistindo em metionina, d-sernina e seus derivados e/ou sais do mesmo. a composição acima referida pode ser uma preparação para a pele externa, um agente antirrugas, um agente de proteção solar, uma composição medicinal para o tratamento e/ou prevenção de doenças de pele, uma composição de alimentos ou um medicamento para a catarata. na composição acima referida para aliviar os danos induzidos por radiação ultravioleta, a dita metionina pode ser d-metionina, e a dita d-serina pode ser derivada de d-cicloserina.
BR112012008146A 2009-09-14 2010-09-14 composição para alívio dos danos causados por meio da irradiação ultravioleta BR112012008146A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2009211255 2009-09-14
JP2009223327 2009-09-28
PCT/JP2010/065789 WO2011030903A1 (ja) 2009-09-14 2010-09-14 紫外線障害軽減組成物

Publications (1)

Publication Number Publication Date
BR112012008146A2 true BR112012008146A2 (pt) 2019-09-24

Family

ID=43732565

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112012008146A BR112012008146A2 (pt) 2009-09-14 2010-09-14 composição para alívio dos danos causados por meio da irradiação ultravioleta

Country Status (12)

Country Link
US (1) US20120148509A1 (pt)
EP (1) EP2478899B1 (pt)
JP (1) JP5795960B2 (pt)
KR (1) KR20120041740A (pt)
CN (1) CN102481278B (pt)
AU (1) AU2010293364A1 (pt)
BR (1) BR112012008146A2 (pt)
ES (1) ES2677618T3 (pt)
HK (1) HK1166708A1 (pt)
RU (1) RU2537187C2 (pt)
TW (1) TWI473624B (pt)
WO (1) WO2011030903A1 (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102481277A (zh) * 2009-09-30 2012-05-30 株式会社资生堂 紫外线损伤减轻口服组合物
JP2013177356A (ja) * 2012-02-29 2013-09-09 Shiseido Co Ltd 紫外線曝露によって促進される血管新生を抑制するための組成物
JP6108170B2 (ja) * 2013-07-30 2017-04-05 株式会社大阪ソーダ 細胞培養用培地
WO2015133591A1 (ja) * 2014-03-05 2015-09-11 株式会社資生堂 表皮セリンラセマーゼ及び／又はｄ－セリン量を指標とした、皮膚のバリア機能亢進薬剤のスクリーニング方法並びに皮膚バリア機能評価方法
WO2015132917A1 (ja) * 2014-03-05 2015-09-11 株式会社資生堂 表皮セリンラセマーゼ及び／又はｄ－セリン量を指標とした、皮膚のバリア機能亢進薬剤のスクリーニング方法並びに皮膚バリア機能評価方法
US20160069867A1 (en) 2014-09-04 2016-03-10 Shiseido Company, Ltd. Method for screening skin barrier function enhancing agent based on epidermal serine racemase and/or d-serine level, and skin barrier function evaluation method
JP6854073B2 (ja) * 2014-03-05 2021-04-07 株式会社 資生堂 表皮セリンラセマーゼ及び／又はｄ−セリン量を指標とした、皮膚のバリア機能亢進薬剤のスクリーニング方法並びに皮膚バリア機能評価方法
KR20160028736A (ko) 2014-09-04 2016-03-14 가부시키가이샤 시세이도 표피 세린 라세마아제 및/또는 d-세린 양을 지표로 하는, 피부 배리어 기능 항진 약제의 스크리닝 방법 및 피부 배리어 기능 평가 방법
US11291654B2 (en) * 2018-09-13 2022-04-05 Syneurx International (Taiwan) Corp. Formulations of cycloserine compounds and applications thereof

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2711976A (en) * 1953-03-27 1955-06-28 American Baking Inst Method of preserving cream-custard type food products and the resulting composition
JPS57158724A (en) * 1981-03-26 1982-09-30 Shiseido Co Ltd Antimicrobial composition
US5378461A (en) * 1991-07-12 1995-01-03 Neigut; Stanley J. Composition for the topical treatment of skin damage
JPH07233046A (ja) * 1993-12-28 1995-09-05 Kose Corp 外用剤
AU1593697A (en) * 1996-01-23 1997-08-20 Chemisch Adviesbureau Drs J.C.P.Schreuder B.V. Composition for treating skin affections and process for its preparation
US5804594A (en) * 1997-01-22 1998-09-08 Murad; Howard Pharmaceutical compositions and methods for improving wrinkles and other skin conditions
JPH1149630A (ja) * 1997-07-31 1999-02-23 Shiseido Co Ltd 美白用化粧料
JPH1160435A (ja) * 1997-08-20 1999-03-02 Shiseido Co Ltd 肌荒れ改善用化粧料
EP2338482A3 (en) * 1998-04-14 2011-12-21 The General Hospital Corporation Methods for treating neuropsychiatric disorders
ES2262322T3 (es) * 1998-06-10 2006-11-16 Meiji Seika Kaisha, Ltd. Tratamiento de la degenaracion espinocereberal y comoposiciones utiles para el tratamiento de degeneracion espinocerebelar.
FR2786690A1 (fr) * 1998-12-08 2000-06-09 Oreal Composition cosmetique deodorante
JP4291628B2 (ja) 2003-06-12 2009-07-08 株式会社資生堂 液体クロマトグラフ装置及び試料に含まれる光学異性体の分析方法
US20050090551A1 (en) * 2003-10-27 2005-04-28 Board Of Trustees Of Southern Illinois University Therapeutic use of methionine for the treatment or prevention of mucositis
AU2005285040A1 (en) * 2004-09-14 2006-03-23 Molecular Therapeutics, Inc. D-methionine formulation with improved biopharmaceutical properties
JP4934812B2 (ja) * 2004-12-21 2012-05-23 国立大学法人 奈良先端科学技術大学院大学 Ｎｆａｔ２発現抑制方法
JP3999249B2 (ja) * 2005-08-08 2007-10-31 株式会社ファンケル 睡眠誘導剤、ストレス性不眠症改善剤
JP4980740B2 (ja) 2007-01-31 2012-07-18 株式会社 資生堂 ２次元液体クロマトグラフィー分析方法および分取用流路切り替えユニット
EP2033689A1 (en) * 2007-08-22 2009-03-11 Italfarmacia S.r.l. Injectable dermatological composition for treatment of the wrinkles
CN102481277A (zh) * 2009-09-30 2012-05-30 株式会社资生堂 紫外线损伤减轻口服组合物

Also Published As

Publication number Publication date
AU2010293364A1 (en) 2012-03-08
RU2012108105A (ru) 2013-10-27
TW201116303A (en) 2011-05-16
EP2478899A1 (en) 2012-07-25
CN102481278A (zh) 2012-05-30
TWI473624B (zh) 2015-02-21
JPWO2011030903A1 (ja) 2013-02-07
JP5795960B2 (ja) 2015-10-14
RU2537187C2 (ru) 2014-12-27
WO2011030903A1 (ja) 2011-03-17
ES2677618T3 (es) 2018-08-03
US20120148509A1 (en) 2012-06-14
EP2478899A4 (en) 2014-06-18
EP2478899B1 (en) 2018-05-09
CN102481278B (zh) 2014-04-16
HK1166708A1 (en) 2012-11-09
KR20120041740A (ko) 2012-05-02

Similar Documents

Publication Publication Date Title
BR112012008146A2 (pt) composição para alívio dos danos causados por meio da irradiação ultravioleta
BR112014014341A2 (pt) Intermediário metilado, seu método de preparação e seus usos, e composição farmacêutica
BR112015025961A2 (pt) composto, composição cosmética ou farmacêutica, e, uso de um composto
EA201690069A1 (ru) Применение высоких доз придопидина для лечения болезни хантингтона
BR112014027860B8 (pt) Moduladores do transporte nuclear e usos dos mesmos
BR112015014585A2 (pt) composto, composição farmacêutica, e, método de tratamento de um ser humano
BR112015029491A2 (pt) derivados de imidazopirrolidinona e seu uso no tratamento de doença
BR112015007083A2 (pt) inibidores de histona demetilases
BR112015004205A2 (pt) sulfamoil-arilamidas e o uso das mesmas como medicamentos para o tratamento da hepatite b
BR112014022106A2 (pt) derivados macrocíclicos para o tratamento de doenças
WO2013022846A3 (en) Flavonoid compounds
BR112015012565A2 (pt) composto, composição cosmética ou farmacêutica, e, uso de um composto
BR112016002465A2 (pt) terapia da combinação para o tratamento de câncer
BR112015012197A8 (pt) usos de inibidores de cdk mtor, e combinação farmacêutica compreendendo os mesmos
BR112013000920A2 (pt) compostos para a redução de produção de beta-amiloide
BR112012021364A2 (pt) "compostos cicloalquila contendo tienopirimidinas e composições farmacêuticas".
BR112014000943A2 (pt) formulação em cápsula que compreende montelukast e levocetirizina
BR112012002553A8 (pt) Composição de proteção solar terapêutica e seus usos
RU2011143736A (ru) Композиции для смягчения поражений, вызванных ультрафиолетовым излучением
BR112013000059A2 (pt) derivados de piperidina e seus usos para o tratamento de distúrbios metabólicos
JP2013500302A5 (pt)
CO6410278A2 (es) Disoluciones pediátricas que continen un beta-bloqueante
BR112012005044A2 (pt) composições que compreendem tramadol e celecoxib no tratamento de dor.
ECSP14013200A (es) Una nueva composición terapéutica que contiene apomorfina como principio activo
BR112012006172A2 (pt) derivados de alqueno oxindol e seus usos para o tratamento de obesidade, diabetes e hiperlipidemia

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2543 DE 01-10-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.